Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population
Lotte Kaasenbrood(SUNY Downstate Health Sciences University), Frank L.J. Visseren(University Medical Center Utrecht), Pierre Amarenco(Assistance Publique – Hôpitaux de Paris), Jan Westerink(Utrecht University), Yolanda van der Graaf(SUNY Downstate Health Sciences University), Maarten J. Cramer(SUNY Downstate Health Sciences University), Ron J.G. Peters(Amsterdam UMC Location University of Amsterdam), L. Jaap Kappelle(University Medical Center Utrecht), John J.P. Kastelein(QRx Pharma (United States)), S. Matthijs Boekholdt(Amsterdam Neuroscience), Kausik K. Ray(Imperial College London), John C. LaRosa(SUNY Downstate Health Sciences University), Gert J. de Borst(Reinier de Graaf Hospital)
Cited by 275
Related Papers
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
|Stroke|1993|12.3k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2021|6.1k